AFFYMAX v. ORTHO-McNEIL-JANSSEN PHARMACEUTICALS

No. 11-2070.

660 F.3d 281 (2011)

AFFYMAX, INC., Plaintiff-Appellee, v. ORTHO-McNEIL-JANSSEN PHARMACEUTICALS, INC., and Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Defendants-Appellants.

United States Court of Appeals, Seventh Circuit.

Decided October 3, 2011.


Attorney(s) appearing for the Case

Richard de Bodo (argued), Attorney, DLA Piper U.S. LLP, Los Angeles, CA, for Plaintiff-Appellee.

Kathleen M. Sullivan (argued), Attorney, Quinn Emanuel Urquhart & Sullivan, LLP, New York, NY, for Defendants-Appellants.

Before EASTERBROOK, Chief Judge, and WOOD and TINDER, Circuit Judges.


EASTERBROOK, Chief Judge.

In 1992 two companies began a joint venture to develop peptide compounds. The parties' names have changed in corporate mergers or restructurings; we use their current names—Affymax and Ortho-McNeil-Janssen Pharmaceuticals (Ortho for short). The agreement provides that any inventions created by the parties' joint efforts are jointly owned, but that inventions attributable to a single party are owned by that party. The agreement also...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases